Matteo Lambertini, MD; Luca Boni, MD; Andrea Michelotti, MD; et al.
This randomized clinical trial evaluates the effects of ovarian suppression using the luteinizing hormone–releasing hormone analogue triptorelin on long-term ovarian function, pregnancies, and disease-free survival among premenopausal women receiving adjuvant breast cancer chemotherapy.